Nachrichten zur Johnson Matthey PLC Aktie

Explainer: Can J&J finally put the talc litigation behind it?

After years of failed attempts to resolve thousands of lawsuits alleging that its talc products caused cancer, Johnson & Johnson…

Johnson & Johnson vs. Eli Lilly: Reliable Stability vs. Rapid Revenue Growth

Johnson & Johnsons revenue has grown modestly while Eli Lillys revenue has nearly doubled in two years, narrowing a once-wide…

J&J-Aktie gefragt: Johnson & Johnson will Talkum-Klagen mit milliardenschwerem Vergleich beilegen

Der US-Pharmakonzern will 5,5 Milliarden US-Dollar zur Beilegung der Klagen bereitstellen. Johnson & Johnson hatte bereits tags zuvor die Konditionen…

Rechtsstreit endet mit Vergleich: Krebserregendes Babypuder? US-Firma zahlt Milliarden

Etliche Klägerinnen werfen Johnson & Johnson vor, durch die Verwendung seiner talkumbasierten Babypuder-Produkte an Eierstockkrebs erkrankt zu sein. Der US-Pharmakonzern…

Stocks making the biggest moves premarket: Coca-Cola, Sherwin-Williams, Johnson & Johnson & more

These are the stocks posting the largest moves in early trading.…

Johnson & Johnson proposes $5.5B settlement to resolve remaining talc litigation

Johnson & Johnson (NYSE:JNJ) has reached an agreement to resolve tens of thousands of lawsuits in the US alleging that…

Johnson & Johnson will 5,5-Milliarden-Vergleich in Babypuder-Prozessen

War Babypuder von Johnson & Johnson krebserregend? Dazu gibt es seit Jahren eine Klagewelle. Der Konzern will diese nun mit…

These 3 Companies Reported Record Results and Raised Guidance

Abbott Laboratories, Taiwan Semiconductor, and Johnson & Johnson have all delivered strong earnings releases in the Q2 cycle, with each…

Johnson & Johnson announces $5.5 billion settlement of talc lawsuits

Johnson & Johnson ?said on Monday it has reached ?a $5.5 billion settlement that will resolve tens of thousands of…

Better Dividend King to Buy Right Now: AbbVie or Johnson & Johnson?

Both have very promising futures.…

Insider trades: Johnson & Johnson, TSMC among notable names

…

Johnson & Johnsons robotic surgery device gets US FDA marketing authorization

Johnson & Johnson said on Wednesday the U.S. ?Food and Drug Administration had granted marketing authorization for its robotic surgery…

Top Analyst Reports for Johnson & Johnson, Lam Research & Seagate

Johnson & Johnson beat Q2 estimates as growth in key drugs, MedTech and its pipeline helps offset Stelara headwinds. Read…

Johnson & Johnson Aktie: Pharma wächst, MedTech bremst

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse der Raiffeisen Bank International AG (RBI):Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI),…

ASML erhöht Gesamtjahresausblick - Apple mit starken iPhone-Verkaufszahlen - PayPal-Aktie im Aufwind

Wien (www.aktiencheck.de) - ASML (0%) konnte gestern die Umsatz- und Gewinnerwartungen für das zweite Quartal 2026 übertreffen, so die Analysten…

+++ Geschäftszahlen +++: Johnson & Johnson hebt Jahresziele an

Börsenrallye und ETF-Boom bescheren BlackRock Rekordergebnis +++ BASF hebt nach Gewinnsprung Jahresziele an Chipausrüster ASML steigert Umsatz +++ Der Newsblog.…

Is Johnson & Johnson a Buy After Its Latest Earnings Report?

Investors didnt seem to think so after the company published it.…

Johnson & Johnson Raises 2026 Outlook After Q2 Earnings Beat

Johnson & Johnson raises its 2026 outlook after Q2 earnings and revenues beat estimates, driven by Innovative Medicine strength and…

Johnson & Johnson Q2-Zahlen: Ausblick erneut leicht angehoben

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse der Raiffeisen Bank International AG (RBI):Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI),…

J&J quarterly earnings beat Wall Street estimates on strength of medicines unit

Johnson & ?Johnson also increased its full-year sales and ?profit ?forecast.…

Johnson & Johnson beats Q2 estimates, raises full-year 2026 guidance

Johnson & Johnson (NYSE:JNJ) reported better-than-expected second quarter results and raised its full-year 2026 outlook, as strong pharmaceutical sales...…

J&J quarterly earnings beat Wall Street estimates on strength of medicines unit

Johnson & Johnson beat Wall Street estimates for second-quarter sales and profit on Wednesday, as strong growth from immunology drug…

Tech Futures Rise With Nasdaq At Key Level; Oil Pushes Above $80

ASML, Johnson & Johnson, PayPal lead early movers on news.…

Johnson & Johnson Aktie: Wachsende Zuversicht

Toronto (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von RBC Capital Markets:RBC Capital habe das Kursziel für die Aktie von Johnson &…

Is Johnson & Johnson Stock Poised for New Highs as Q2 Results Approach?

After hitting fresh all-time highs last week, investors are turning their attention to JNJs Q2 report, which is scheduled for…

Q2 Earnings Season Arrives: Can Results Match Upbeat Expectations?

The big banks dominate this weeks reporting docket, though several notable companies from other sectors will also report, including Netflix,…

Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?

Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key…

Johnson & Johnson (JNJ) Declines More Than Market: Some Information for Investors

Johnson & Johnson (JNJ) closed at $263.4 in the latest trading session, marking a -1.44% move from the prior day.…

Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Johnson & Johnson Is Walking Away From a $100 Billion Obesity Market. Could That Actually Make It the Better Long-Term Buy Than Eli Lilly?

Johnson & Johnson doesnt need GLP-1 drugs to grow, and thats good news for long-term investors.…

[Latest] Global Gauze Bandage Rolls Market Size/Share Worth USD 3.19 Billion by 2035 at a 4.97% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Gauze…

Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

Bristol Myers Squibb trades at a deep discount, while Johnson & Johnson boasts higher margins and a broader reach. How…

Johnson & Johnson snaps six straight sessions of gains

…

Johnson & Johnson (JNJ) Surges 4.0%: Is This an Indication of Further Gains?

Johnson & Johnson (JNJ) saw its shares surge in the last session with trading volume being higher than average. The…

Johnson & Johnson Aktie: Weiteres Potenzial vor den Zahlen

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Guggenheim Securities:Guggenheim-Analyst Vamil Divan habe das Kursziel für die Aktie von Johnson…

J&J CEO Now Sees Line of Sight to Double-Digit Growth for His $100 Billion Company. Heres Why Investors Should Pay Attention.

Johnson & Johnson is a healthcare giant, but an opportunity to invest in the United States and a plethora of…

Johnson & Johnson (JNJ) Rises As Market Takes a Dip: Key Facts

Johnson & Johnson (JNJ) concluded the recent trading session at $244.88, signifying a +1.61% move from its prior days close.…

Ausbruch dank Novo Nordisk, UnitedHealth und Johnson & Johnson?

Der Chart sieht spannend aus. Dank der zuletzt soliden Performance von Aktien wie UnitedHealth, Novo Nordisk oder Johnson & Johnson…

Ausbruch dank Novo Nordisk, UnitedHealth und Johnson & Johnson?

Der Chart sieht spannend aus. Dank der zuletzt soliden Performance von Aktien wie UnitedHealth, Novo Nordisk oder Johnson & Johnson…

Johnson & Johnson (JNJ) Could Be a Great Choice

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Top Research Reports for Alphabet, Broadcom & Johnson & Johnson

Todays Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Broadcom Inc. (AVGO) and Johnson…

Johnson & Johnson to invest $1 billion in vision operations in Jacksonville

With $12 million in city incentives in hand, the company is building a distribution center in Northwest Jacksonville and upgrading…

Johnson & Johnson (JNJ) Rises Higher Than Market: Key Facts

Johnson & Johnson (JNJ) closed at $240.87 in the latest trading session, marking a +1.07% move from the prior day.…

Johnson & Johnson bets $1 billion on hard-to-treat cancer

Johnson & Johnson (JNJ) is one of the biggest names in health care, and lately, its stock has been living…

Johnson & Johnson to buy Firefly Bio for $1 billion

Johnson & Johnson said ?on Monday it will acquire ?biotech Firefly Bio for $1 billion in cash, as it ?looks…

Why Johnson & Johnson May Be the Closest Thing Investors Can Find to a Bulletproof Dividend Stock

Johnson & Johnson takes a licking, and the dividend keeps on ticking higher.…

Johnson & Johnson (JNJ) Exceeds Market Returns: Some Facts to Consider

In the latest trading session, Johnson & Johnson (JNJ) closed at $228.17, marking a +2.21% move from the previous day.…

Are You Looking for a High-Growth Dividend Stock?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study

BEERSE, BELGIUM , June 03, 2026 (GLOBE NEWSWIRE) -- Johnson & Johnson today announced nipocalimab met the…

Johnson & Johnson (JNJ) Stock Slides as Market Rises: Facts to Know Before You Trade

Johnson & Johnson (JNJ) reached $225.33 at the closing of the latest trading day, reflecting a -2.37% change compared to…